Therapeutic Advances in Diabetic Nephropathy

Diabetic kidney disease (DKD) is the most common cause of end-stage kidney disease (ESKD) in the United States. Risk factor modification, such as tight control of blood glucose, management of hypertension and hyperlipidemia, and the use of renin–angiotensin–aldosterone system (RAAS) blockade have be...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawaf, Hanny, Thomas, George, Taliercio, Jonathan J., Nakhoul, Georges, Vachharajani, Tushar J., Mehdi, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781778/
https://www.ncbi.nlm.nih.gov/pubmed/35054076
http://dx.doi.org/10.3390/jcm11020378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781778/
https://www.ncbi.nlm.nih.gov/pubmed/35054076
http://dx.doi.org/10.3390/jcm11020378

Ejemplares similares